We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$7.54B
AUM Growth
+$509M
Cap. Flow
+$81.8M
Cap. Flow %
1.08%
Top 10 Hldgs %
15.04%
Holding
1,277
New
87
Increased
539
Reduced
599
Closed
49

Sector Composition

Rank Sector Weight
1 Technology 21.29%
2 Healthcare 13.85%
3 Financials 13.17%
4 Consumer Discretionary 10.27%
5 Industrials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IR icon
576
Ingersoll Rand
IR
$33.7B
$1.86M 0.02%
30,106
-1,015
-3% -$57.8K
SLAB icon
577
Silicon Laboratories
SLAB
$7.23B
$1.85M 0.02%
8,983
-367
-4% -$67.6K
SWK icon
578
Stanley Black & Decker
SWK
$15.7B
$1.85M 0.02%
9,815
-1,030
-9% -$190K
HCSG icon
579
Healthcare Services Group
HCSG
$1.53B
$1.85M 0.02%
103,939
-159,135
-60% -$3.09M
RDS.A
580
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.85M 0.02%
42,554
+11,796
+38% +$533K
EXAS
581
DELISTED
Exact Sciences
EXAS
$1.84M 0.02%
23,629
+471
+2% +$41.6K
QTWO icon
582
Q2 Holdings
QTWO
$3.92B
$1.84M 0.02%
23,119
+7,707
+50% +$622K
ABG icon
583
Asbury Automotive
ABG
$3.85B
$1.82M 0.02%
10,524
-1,034
-9% -$190K
ATO icon
584
Atmos Energy
ATO
$28.8B
$1.81M 0.02%
17,280
+4,230
+32% +$401K
EGP icon
585
EastGroup Properties
EGP
$10.9B
$1.8M 0.02%
7,912
+1,144
+17% +$230K
ZBH icon
586
Zimmer Biomet
ZBH
$18.4B
$1.8M 0.02%
14,570
+2,946
+25% +$386K
BSX icon
587
Boston Scientific
BSX
$71.5B
$1.78M 0.02%
41,934
-3,395
-7% -$143K
DE icon
588
Deere & Co
DE
$168B
$1.77M 0.02%
5,175
+3,076
+147% +$1.07M
TDG icon
589
TransDigm Group
TDG
$67.7B
$1.77M 0.02%
2,786
-206
-7% -$129K
ITUB icon
590
Itaú Unibanco
ITUB
$87.5B
$1.77M 0.02%
534,111
-304,518
-36% -$1.1M
CS
591
DELISTED
Credit Suisse Group
CS
$1.77M 0.02%
183,359
-7,857
-4% -$78.5K
REGN icon
592
Regeneron Pharmaceuticals
REGN
$80.8B
$1.77M 0.02%
2,799
-88
-3% -$54.1K
L icon
593
Loews
L
$23.6B
$1.76M 0.02%
30,510
-674
-2% -$38.2K
RNR icon
594
RenaissanceRe
RNR
$13.4B
$1.75M 0.02%
10,363
+2,708
+35% +$424K
INGR icon
595
Ingredion
INGR
$6.58B
$1.75M 0.02%
18,133
-556
-3% -$53.5K
CTXS
596
DELISTED
Citrix Systems Inc
CTXS
$1.75M 0.02%
18,451
-4,419
-19% -$404K
UGI icon
597
UGI
UGI
$7.33B
$1.73M 0.02%
37,740
+272
+0.7% +$12.1K
NLSN
598
DELISTED
Nielsen Holdings plc
NLSN
$1.73M 0.02%
84,216
+1,241
+1% +$25.3K
NBIS
599
Nebius Group N.V.
NBIS
$47.7B
$1.71M 0.02%
28,273
-269
-0.9% -$19.8K
ORLY icon
600
O'Reilly Automotive
ORLY
$76.3B
$1.7M 0.02%
36,120
-11,280
-24% -$488K

Similar funds

Oppenheimer Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Oppenheimer Asset Management held 1,277 positions worth $7.54B, up 7.2% from $7.03B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Oppenheimer Asset Management's Q4 2021 filing shows 87 new, 539 increased, 599 reduced and 49 closed positions. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 241,081 shares worth $14.8M. The largest sale was Autodesk, an estimated $9.15M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer Asset Management's largest Q4 2021 buy was Vanguard FTSE All-World ex-US ETF: 241,081 shares worth $14.8M.
  • Oppenheimer Asset Management added most to iShares Currency Hedged MSCI EAFE ETF in Q4 2021, an estimated $18.6M increase.
  • Oppenheimer Asset Management's biggest Q4 2021 reduction was Autodesk, cutting an estimated $9.15M.
  • Oppenheimer Asset Management fully exited iShares MSCI EAFE Growth ETF in Q4 2021, selling an estimated $7.45M.
  • Oppenheimer Asset Management's ten largest holdings make up 15% of its $7.54B portfolio in Q4 2021.
  • Oppenheimer Asset Management opened 87 new positions and closed 49 in Q4 2021.
  • Oppenheimer Asset Management's portfolio value rose 7.2% quarter-over-quarter to $7.54B.

Based on Oppenheimer Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.